Rheumatoid Arthritis
VIDEO: ‘Don’t taper’ TNF inhibitors for patients with RA in sustained remission
SAN DIEGO — Healio spoke with Kathryn Dao, MD, about a study assessing the effects of tapering to withdraw of TNF inhibitors compared with stable use among patients with rheumatoid arthritis.
VIDEO: TNF inhibitors appear safe for patients with RA-associated ILD
SAN DIEGO — Kathryn Dao, MD, discusses a study presented at ACR Convergence 2023 that compared the initiation of TNF inhibitors with non-TNF inhibitor biologics or JAK inhibitors among patients with rheumatoid arthritis-associated interstitial lung disease.
VIDEO: Efficacious split-dosing of high-dose methotrexate in patients with RA
SAN DIEGO — In this video, Healio spoke with Kathryn Dao, MD, about the SMART study presented at ACR Convergence 2023.
Split-dose methotrexate lowers need for more DMARDs vs single dose in rheumatoid arthritis
SAN DIEGO — Split-dose methotrexate had greater efficacy and reduced the need for additional disease-modifying antirheumatic drugs at 16 weeks vs. a single dose for rheumatoid arthritis, according to data presented at ACR Convergence 2023.
Patients with rheumatoid arthritis report ‘many symptoms’ of long COVID prior to infection
SAN DIEGO — Patients with rheumatoid arthritis who reported having long COVID in the past year demonstrated “many symptoms” of long COVID prior to initial infection,” according to data presented at ACR Convergence 2023.
PCP training improves rheumatoid arthritis care in underserved Native American populations
SAN DIEGO — A 12-week, remote training program improved rheumatoid arthritis knowledge and clinical behaviors among PCPs in underserved Native American populations across the United States, according to speaker at ACR Convergence 2023.
Physical therapy app, provider phone calls improve rheumatoid arthritis fatigue, self-care
SAN DIEGO — A remote, technology-based physical therapy intervention that included phone calls with a health care provider improved self-management and physical activity in patients with rheumatoid arthritis, according to a speaker.
Hydroxychloroquine use predicts lower risk for fatty liver disease in rheumatoid arthritis
SAN DIEGO — Patients with rheumatoid arthritis who receive hydroxychloroquine demonstrate a lower risk for nonalcoholic fatty liver disease, according to data presented at ACR Convergence 2023.
Real-world monitoring of rheumatoid arthritis-associated ILD ‘suboptimal’
SAN DIEGO — Monitoring of rheumatoid arthritis-associated interstitial lung disease remains highly variable and “suboptimal” in the real world, according to a speaker at ACR Convergence 2023.
Menopausal hormone therapy may increase risk for late-onset rheumatoid arthritis
Oral contraceptives may protect against rheumatoid arthritis, while menopausal hormone therapy could increase risk for late-onset RA, according to data published in Rheumatology.